Cargando…

Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women

BACKGROUND: Soy isoflavones show structural and functional similarities to estradiol. Available data indicate that estradiol and estradiol-like components may interact with gut "satiety hormones" such as peptide YY (PYY) and ghrelin, and thus influence body weight. In a randomized, double-...

Descripción completa

Detalles Bibliográficos
Autores principales: Weickert, Martin O, Reimann, Manja, Otto, Bärbel, Hall, Wendy L, Vafeiadou, Katherina, Hallund, Jesper, Ferrari, Marika, Talbot, Duncan, Branca, Francesco, Bügel, Susanne, Williams, Christine M, Zunft, Hans-Joachim, Koebnick, Corinna
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1562443/
https://www.ncbi.nlm.nih.gov/pubmed/16907966
http://dx.doi.org/10.1186/1477-5751-5-11
_version_ 1782129504010895360
author Weickert, Martin O
Reimann, Manja
Otto, Bärbel
Hall, Wendy L
Vafeiadou, Katherina
Hallund, Jesper
Ferrari, Marika
Talbot, Duncan
Branca, Francesco
Bügel, Susanne
Williams, Christine M
Zunft, Hans-Joachim
Koebnick, Corinna
author_facet Weickert, Martin O
Reimann, Manja
Otto, Bärbel
Hall, Wendy L
Vafeiadou, Katherina
Hallund, Jesper
Ferrari, Marika
Talbot, Duncan
Branca, Francesco
Bügel, Susanne
Williams, Christine M
Zunft, Hans-Joachim
Koebnick, Corinna
author_sort Weickert, Martin O
collection PubMed
description BACKGROUND: Soy isoflavones show structural and functional similarities to estradiol. Available data indicate that estradiol and estradiol-like components may interact with gut "satiety hormones" such as peptide YY (PYY) and ghrelin, and thus influence body weight. In a randomized, double-blind, placebo-controlled, cross-over trial with 34 healthy postmenopausal women (59 ± 6 years, BMI: 24.7 ± 2.8 kg/m(2)), isoflavone-enriched cereal bars (50 mg isoflavones/day; genistein to daidzein ratio 2:1) or non-isoflavone-enriched control bars were consumed for 8 weeks (wash-out period: 8-weeks). Seventeen of the subjects were classified as equol producers. Plasma concentrations of ghrelin and PYY, as well as energy intake and body weight were measured at baseline and after four and eight weeks of each intervention arm. RESULTS: Body weight increased in both treatment periods (isoflavone: 0.40 ± 0.94 kg, P < 0.001; placebo: 0.66 ± 0.87 kg, P = 0.018), with no significant difference between treatments. No significant differences in energy intake were observed (P = 0.634). PYY significantly increased during isoflavone treatment (51 ± 2 pmol/L vs. 55 ± 2 pmol/L), but not during placebo (52 ± 3 pmol/L vs. 50 ± 2 pmol/L), (P = 0.010 for treatment differences, independent of equol production). Baseline plasma ghrelin was significantly lower in equol producers (110 ± 16 pmol/L) than in equol non-producers (162 ± 17 pmol/L; P = 0.025). CONCLUSION: Soy isoflavone supplementation for eight weeks did not significantly reduce energy intake or body weight, even though plasma PYY increased during isoflavone treatment. Ghrelin remained unaffected by isoflavone treatment. A larger and more rigorous appetite experiment might detect smaller differences in energy intake after isoflavone consumption. However, the results of the present study do not indicate that increased PYY has a major role in the regulation of body weight, at least in healthy postmenopausal women.
format Text
id pubmed-1562443
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-15624432006-09-08 Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women Weickert, Martin O Reimann, Manja Otto, Bärbel Hall, Wendy L Vafeiadou, Katherina Hallund, Jesper Ferrari, Marika Talbot, Duncan Branca, Francesco Bügel, Susanne Williams, Christine M Zunft, Hans-Joachim Koebnick, Corinna J Negat Results Biomed Research BACKGROUND: Soy isoflavones show structural and functional similarities to estradiol. Available data indicate that estradiol and estradiol-like components may interact with gut "satiety hormones" such as peptide YY (PYY) and ghrelin, and thus influence body weight. In a randomized, double-blind, placebo-controlled, cross-over trial with 34 healthy postmenopausal women (59 ± 6 years, BMI: 24.7 ± 2.8 kg/m(2)), isoflavone-enriched cereal bars (50 mg isoflavones/day; genistein to daidzein ratio 2:1) or non-isoflavone-enriched control bars were consumed for 8 weeks (wash-out period: 8-weeks). Seventeen of the subjects were classified as equol producers. Plasma concentrations of ghrelin and PYY, as well as energy intake and body weight were measured at baseline and after four and eight weeks of each intervention arm. RESULTS: Body weight increased in both treatment periods (isoflavone: 0.40 ± 0.94 kg, P < 0.001; placebo: 0.66 ± 0.87 kg, P = 0.018), with no significant difference between treatments. No significant differences in energy intake were observed (P = 0.634). PYY significantly increased during isoflavone treatment (51 ± 2 pmol/L vs. 55 ± 2 pmol/L), but not during placebo (52 ± 3 pmol/L vs. 50 ± 2 pmol/L), (P = 0.010 for treatment differences, independent of equol production). Baseline plasma ghrelin was significantly lower in equol producers (110 ± 16 pmol/L) than in equol non-producers (162 ± 17 pmol/L; P = 0.025). CONCLUSION: Soy isoflavone supplementation for eight weeks did not significantly reduce energy intake or body weight, even though plasma PYY increased during isoflavone treatment. Ghrelin remained unaffected by isoflavone treatment. A larger and more rigorous appetite experiment might detect smaller differences in energy intake after isoflavone consumption. However, the results of the present study do not indicate that increased PYY has a major role in the regulation of body weight, at least in healthy postmenopausal women. BioMed Central 2006-08-14 /pmc/articles/PMC1562443/ /pubmed/16907966 http://dx.doi.org/10.1186/1477-5751-5-11 Text en Copyright © 2006 Weickert et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Weickert, Martin O
Reimann, Manja
Otto, Bärbel
Hall, Wendy L
Vafeiadou, Katherina
Hallund, Jesper
Ferrari, Marika
Talbot, Duncan
Branca, Francesco
Bügel, Susanne
Williams, Christine M
Zunft, Hans-Joachim
Koebnick, Corinna
Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women
title Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women
title_full Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women
title_fullStr Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women
title_full_unstemmed Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women
title_short Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women
title_sort soy isoflavones increase preprandial peptide yy (pyy), but have no effect on ghrelin and body weight in healthy postmenopausal women
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1562443/
https://www.ncbi.nlm.nih.gov/pubmed/16907966
http://dx.doi.org/10.1186/1477-5751-5-11
work_keys_str_mv AT weickertmartino soyisoflavonesincreasepreprandialpeptideyypyybuthavenoeffectonghrelinandbodyweightinhealthypostmenopausalwomen
AT reimannmanja soyisoflavonesincreasepreprandialpeptideyypyybuthavenoeffectonghrelinandbodyweightinhealthypostmenopausalwomen
AT ottobarbel soyisoflavonesincreasepreprandialpeptideyypyybuthavenoeffectonghrelinandbodyweightinhealthypostmenopausalwomen
AT hallwendyl soyisoflavonesincreasepreprandialpeptideyypyybuthavenoeffectonghrelinandbodyweightinhealthypostmenopausalwomen
AT vafeiadoukatherina soyisoflavonesincreasepreprandialpeptideyypyybuthavenoeffectonghrelinandbodyweightinhealthypostmenopausalwomen
AT hallundjesper soyisoflavonesincreasepreprandialpeptideyypyybuthavenoeffectonghrelinandbodyweightinhealthypostmenopausalwomen
AT ferrarimarika soyisoflavonesincreasepreprandialpeptideyypyybuthavenoeffectonghrelinandbodyweightinhealthypostmenopausalwomen
AT talbotduncan soyisoflavonesincreasepreprandialpeptideyypyybuthavenoeffectonghrelinandbodyweightinhealthypostmenopausalwomen
AT brancafrancesco soyisoflavonesincreasepreprandialpeptideyypyybuthavenoeffectonghrelinandbodyweightinhealthypostmenopausalwomen
AT bugelsusanne soyisoflavonesincreasepreprandialpeptideyypyybuthavenoeffectonghrelinandbodyweightinhealthypostmenopausalwomen
AT williamschristinem soyisoflavonesincreasepreprandialpeptideyypyybuthavenoeffectonghrelinandbodyweightinhealthypostmenopausalwomen
AT zunfthansjoachim soyisoflavonesincreasepreprandialpeptideyypyybuthavenoeffectonghrelinandbodyweightinhealthypostmenopausalwomen
AT koebnickcorinna soyisoflavonesincreasepreprandialpeptideyypyybuthavenoeffectonghrelinandbodyweightinhealthypostmenopausalwomen